期刊文献+

我国基本药物制度绩效评估指标体系初探 被引量:15

Preliminary Study on the Establishment of Performance Indicator System for Evaluating National Essential Drug System in China
原文传递
导出
摘要 目的:对构建我国基本药物制度绩效评估指标体系进行初步探讨。方法:结合政策绩效评估的理论与方法,以世界卫生组织(WHO)的国家药物政策绩效评估指标为基础,参考国内、外卫生政策领域绩效评估研究实践,进行定性研究。结果与结论:构建我国基本药物制度绩效评估指标体系,需先明确基本药物制度的目标、评价标准和基本药物制度内容等,在此基础上构建指标体系框架,并结合WHO推荐指标、调研结果及专家咨询结果,构建具体指标体系。 OBJECTIVE : To explore the establishment of performance indicator system for evaluating national essential drug system in China. METHODS : Reference to the field of health policy performance evaluation research and practice at home and abroad. WHO indicators for evaluating national drug policies, and a qualitative study on the theory and approach of policy evaluation was conducted. RESULTS & CONCLUSION: To establish a China-specific performance evaluation indicator system, policy goals should be specified, and evaluation criterions and policy components should be also defined firstly. An indicator system framework of national essential drug system which based on WHO recommendatory indicators should be proposed accordingly. But detailed indicators should be established based on field research and experts counseling.
出处 《中国药房》 CAS CSCD 北大核心 2010年第8期683-685,共3页 China Pharmacy
关键词 基本药物制度 绩效评估 WHO国家药物政策 指标体系 Essential drug system Performance evaluation WHO national medicine policy Indicator system
  • 相关文献

参考文献8

  • 1威廉·N·邓恩.公共政策分析导论[M].第2版.北京:中国人民大学出版社,2002:436.
  • 2Adevis Donabedian著,李岩译.医疗质量评估与监测[M].北京:北京大学医学出版社&北京大学出版社,2007:27-61.
  • 3WHO. How to investigate drug use in health facilities[EB/ OL]. http: // apps. who. int/medicinedocs/en/d/Js2289e/. 1993.2009-12.
  • 4WHO. A practical manual: Indicators for monitoring national drug policies[EB/OL]. The second edition http ://apps.who.int/bookorders/anglais/detart1.j sp?sesslan = 1&codlan = 1 &codcol = 93&codcch = 2066.1999.2009-12.
  • 5WHO/HAI. Measuring medicine prices, availability, afrordability and price components[EB/OL].The second.edition.http://www.who.int/medicines/areas/access/medicines_ prices08/en/index.html. 2008.2009-12.
  • 6WHO. Operational package for assessing, monitoring and evaluating country pharmaceutical situations[EB/OL]http.,//www.who.int/medicines/publications/WHO_TCM_ 2007.2/en/index.html.2007.2009-12.
  • 7刘宝,武瑞雪,叶露.论基本药物的可获得性和可及性障碍[J].中国药房,2007,18(14):1041-1043. 被引量:45
  • 8诸大建,刘淑妍,朱德米,等.政策分析新模式[M].上海:同济大学出版社,2007:145.

二级参考文献11

  • 1韩希成.医疗机构药品集中招标采购中的监督管理亟待加强[J].中国药房,2005,16(13):964-966. 被引量:7
  • 2顾海,唐艳,邓晨珂.我国药品集中招标采购制度的缺陷和对策[J].卫生经济研究,2006,23(7):28-29. 被引量:6
  • 3龚翔.利润薄,认知度低,遴选机制不健全--基本药物市场缺货,谁之过?[N].中国医药报,2004年10月14日(A1).
  • 4World Health Organization.The selection and use of essential medicines:report of the WHO expert committee (including the 14th model list of essential medicines)[R].Geneva:World Health Organization,2006.
  • 5央视国际.降价10年,廉价药"退守"农村市场[EB/OL].http://news.cctv.com/society/20070409/101607.html.2007.
  • 6李晓宏.经典廉价药,医院难找到(廉价药为何短缺②)[N].人民日报,2006,3,29.
  • 7卫生部,国家发展改革委员会,国家工商总局,国家食品药品监督管理局,国家中医药管理局,国务院纠风办.关于进一步规范医疗机构药品集中招标采购的若干规定[S].2004,10,11.
  • 8李玮颖,顾意亮.民革上海市委一份提案:廉价经典药又回来了[EB/OL].http://cppcc.people.com.cn/GB/34952/3582409.html.2005.
  • 9王银华.上海廉价药复出市场有望[N].中国医药报,2006,3,23.
  • 10杨升华,陈凤琼.价格低廉厂家不愿生产,廉价救命药"濒危"[EB/OL].http://www.ycwb.com/xkb/2006-10/25/content_1256213.htm.2006.

共引文献51

同被引文献138

引证文献15

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部